Lactate or bicarbonate in dialysis fluid for daily home hemodialysis: advantages and disadvantages

Authors

DOI:

https://doi.org/10.25796/bdd.v6i2.78643

Keywords:

daily hemodialysis, low dialysate flow rate

Abstract

The availability since the beginning of the 20th century of hemodialysis monitors similar to the cyclers used for automated peritoneal dialysis (space-saving and easy-to-handle monitors using a low volume of dialysis fluid and suitable for daily dialysis) has led to renewed interest in home hemodialysis. As in peritoneal dialysis, these cyclers use either lactate - an anion whose metabolism leads to bicarbonate regeneration - or bicarbonate in the dialysate. The purpose of this article is to review the advantages and disadvantages of these two types of alkalinizing anion. Whichever type of anion is used, it is important to avoid over-alkalinization of the patient. Lactate dialysate, which is less expensive and easier to handle, seems to be suitable for most patients, but its use in patients with abnormal liver function should be discouraged.

Introduction

Under normal dietary conditions and as a result of nutrient metabolism, the body is continuously subjected to an acid load:

- volatile acid load due to carbon dioxide (CO2), mainly from aerobic glucose metabolism: carbon dioxide is present in the body in dissolved form, behaving like a weak acid (partially dissociated acid). This acid is volatile, as it is eliminated by the lungs in the form of carbon dioxide.

- load in non-volatile acids (called fixed acids) which behave like strong acids (totally dissociated at the body’s pH). The load of fixed mineral acids (mainly sulfuric acid from amino acid metabolism, but also acids from the diet) is around 1 mEq per day per kg of body weight and is normally eliminated by the kidneys. The load of fixed organic acids (lactic acid, pyruvic acid, etc.) from carbohydrate and lipid metabolism is much higher but does not affect the acid-base balance because the corresponding anion (lactate, pyruvate, acetate, citrate, etc.) is metabolizable and alkalinizing: indeed, the metabolism of these anions (consuming oxygen), which takes place mainly in the liver and muscle, leads to the appearance of bicarbonate, which takes over the H+ ions provided by these acids.

As the kidneys of the dialysis patient no longer eliminate the load of fixed mineral acids, this leads to a drop in bicarbonate level (metabolic acidosis). Moreover, dialysis is responsible for the loss of alkalizing organic anions not present in the dialysate, which exacerbates metabolic acidosis and the drop in bicarbonates.

The dialysis session must be capable of restoring bicarbonatemia. The most logical approach would seem to be to provide the missing bicarbonate using a dialysis fluid with a higher bicarbonate concentration than the patient. As dialysis fluid must also contain divalent ions (calcium and magnesium), which have a strong tendency to precipitate as insoluble calcium and magnesium carbonates, it is necessary to acidify the dialysate to prevent this precipitation.

The method used in the early days of hemodialysis consisted of acidifying the dialysate by dissolving carbon dioxide contained in a cylinder. Since this method was very cumbersome to implement, Charles Mion, then working in Belding Scribner’s team in Seattle, proposed substituting the bicarbonate in the dialysate by acetate, an alkalinizing anion that does not precipitate calcium and magnesium salts[1]. Acetate was also chosen for the same reason during the development of continuous ambulatory peritoneal dialysis (CAPD) using bags of sterile dialysis fluid.

Progressive improvements in access to hemodialysis have made it possible to care for increasingly frail and elderly patients. However, the deleterious effects of acetate often make such treatment impossible. Technological advances have made it possible to manufacture a bicarbonate dialysate extemporaneously, without the need for a CO2 cylinder, and this type of dialysate became increasingly popular in the last two decades of the 20th century[2]. At the same time, acetate was found to be responsible for sclerosing peritonitis in patients treated with CAPD[3]and was replaced by lactate.

At the start of the 21st century, the benefits of short daily hemodialysis are becoming increasingly apparent, both in medical terms and in terms of quality of life. Its main (and perhaps only!) disadvantage is that, when performed in a center, it doubles the time and cost of transport, which are already very high. The development of simplified monitors to promote short daily home hemodialysis is therefore justified. This type of hemodialysis is carried out using low-flow dialysate[4], based on the example of peritoneal dialysis cyclers: space-saving, easy-to-handle monitors, suitable for daily dialysis and requiring only a small volume of dialysis fluid supplied in bags in which the alkalinizing ion is lactate or bicarbonate.

To my knowledge, there are as yet no published studies comparing the use of lactate and bicarbonate in short daily home hemodialysis. That’s why we’ll start with conventional hemodialysis. Although acetate dialysate is virtually no longer used, it will be mentioned in the preamble because acetate is a metabolizable alkalizing ion and, as such, shares properties with lactate. In chronic hemodialysis, there have been far more publications in the literature on acetate dialysate than on lactate dialysate.

Acetate buffered dialysate

The replacement of bicarbonate with acetate in the dialysate results in a significant loss of bicarbonate in the dialysate. A high acetate concentration (35 to 45 mmol/L) is therefore required to compensate for both bicarbonate consumption during the interdialytic period and bicarbonate and inorganic anions loss during the dialysis session. The result is a significant rise in acetatemia (normal: 0.01 to 0.3 mmol/L) during dialysis, which can reach over 4 mmol/L in some patients with particularly slow acetate metabolism[6].

The presence of acetate in the dialysate is responsible for several deleterious effects. The higher the acetate level, the greater the vasodilatation. This vasodilatation leads to a drop in blood pressure despite the increase in heart rate, resulting in hemodynamic instability. The presence of acetate in the dialysate is also responsible for abnormalities in lipid and carbohydrate[7]metabolism as well as stimulation of inflammation (production of TNF and IL1-β), explaining a mild febrile reaction[8][9].

In addition, the loss of dissolved CO2in the dialysate, due to its absence in the dialysate, induces respiratory alkalosis, as evidenced by the decrease in PCO2of around 4 mmHg during the session[7]. This respiratory alkalosis explains the maintenance or even slight increase in

.....

References

Mion CM, Hegstrom RM, Boen ST, Scribner BH.

Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis.

Trans Am Soc Artif Intern Organs 1964, 10: 110-113.

Graefe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH.

Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate.

Ann Intern Med 1978, 88: 332-336.

Faller B, Marichal JF.

Loss of ultrafiltration in continuous ambulatory peritoneal dialysis : A role for acetate.

Peritoneal Dial Bull 1984, 4: 10-13.

Cherukuri S, Bajo M, Colussi G, Corciulo R, Fessi H, Ficheux M, Slon M, Weinhandl E, Borman N.

Home hemodialysis treatment and outcomes: retrospective analysis of the Knowledge to Improve Home Dialysis Network in Europe (KIHDNEy) cohort.

BMC Nephrol 2018, 19: 262.

Fessi H, Szelag JC, Courivaud C, Nicoud P, Aguilera D, Gilbert O, Morena M, Thomas M, Canaud B, Cristol JP.

Safety and efficacy of short daily hemodialysis with Physidia S3 system : Clinical performance assessment during the training period.

J Clin Med 2023, 12: 1357.

Scheppach W, Kortmann B, Burghardt W, Keller F, Kasper H, Bahner U, Teschner M, Heidland A.

Effects of acetate during regular hemodialysis.

Clin Nephrol 1988, 29: 19-27.

Veech RL.

The untoward effects of the anions of dialysis fluids.

Kidney Int 1988, 34: 587-597.

Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S.

Enhancement of in-vitro human interleukin-1 production by sodium acetate.

Lancet 1987, ii: 14-16.

Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA.

Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes.

Lymphokine Res 1987, 6: 63-70.

Hakim RM, Pontzer MA, Tilton D, Lazarus JM, Gottlieb MN.

Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients.

Kidney Int 1985, 28: 535-540.

Fournier G, Potier J, Thebaud HE, Majdalani G, Ton-That H, Man NK.

Substitution of acetic acic for hydrochloric acid in the bicarbonate buffered dialysate.

Artif Organs 1998, 22: 608-613.

Leunissen KM, van den Berg BW, van Hooff JP.

Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis.

Blood Purif 1989, 7: 233-239.

Hood VL, Tannen RL.

Protection of acid-base balance by pH regulation of acid production.

N Engl J Med 1998, 339: 819-826.

Leunissen KM, Claessens PJ, Mooy JM, van Hooff JP, Shaldon S.

Chronic haemodialysis with bicarbonate dialysate. Technical and clinical aspects.

Blood Purif 1990, 8: 347-358.

Ganss R, Aarseth HP, Nordby G.

Prevention of hemodialysis associated hypoxemia by use of low-concentration bicarbonate dialysate.

ASAIO J 1992, 38: 820-822.

Symreng T, Flanigan MJ, Lim VS.

Ventilatory and metabolic changes during high-efficiency hemodialysis.

Kidney Int 1992, 41: 1064-1069.

Mudge GH, Manning JA, Gilman A.

Sodium acetate as a source of fixed base.

Proc Soc Exp Biol Med 1949, 71: 136-138.

Hartmann AF.

Theory and practice of parenteral fluid administration.

JAMA 1934, 103: 1349-1354.

Dalal S, Yu AW, Gupta DK, Kar PM, Ing TS, Daugirdas JT.

L-Lactate high-efficiency hemodialysis : hemodynamics, blood gas changes, potassium/phosphorus, and symptoms.

Kidney Int 1990, 38: 896-903.

Dalal SP, Ajam M, Gupta DK, Gupta R, Nawab Z, Manahan FJ, Ing TS, Daugirdas JT.

L-Lactate for high-efficiency hemodialysis : feasibility studies and a randomized comparison with acetate and bicarbonate.

Int J Artif Organs 1989, 12: 611-617.

Davenport A, Will EJ, Davison AM.

The effect of lactate-buffered solutions on the acid-base status of patients with renal failure.

Nephrol Dial Transplant 1989, 4: 800-804.

Thomas AN, Guy JM, Kishen R, Geraghty IF, Bowles BJM, Vadgama P.

Comparison of lactate and bicarbonate buffered haemofiltration fluids : use in critically ill patients.

Nephrol Dial Transplant 1997, 12: 1212-1217.

Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chioléro RL.

Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure.

Intensive care Med 2004, 30: 1103-1110.

Kierdorf HP, Leue C, Arns S.

Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies.

Kidney Int 1999, 56(Suppl 72): S32-S36.

Heering P, Ivens K, Thümer O, Braüse M, Grabensee B.

Acid-base balance and substitution fluid during continuous hemofiltration.

Kidney Int 1999, 56(Suppl 72): S37-S40.

Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW.

Association of predialysis sodium bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Am J Kidney Dis 2004, 44: 661-671.

Submitted

2023-06-21

Accepted

2023-06-26

Published

2023-07-18

How to Cite

1.
Petitclerc T. Lactate or bicarbonate in dialysis fluid for daily home hemodialysis: advantages and disadvantages. Bull Dial Domic [Internet]. 2023 Jul. 18 [cited 2025 Nov. 1];6(2):51-8. Available from: https://bdd.rdplf.org/index.php/bdd/article/view/78643